Fidelity Investments’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $937 | Buy |
234
+229
| +4,580% | +$917 | ﹤0.01% | 4974 |
|
2025
Q1 | $17 | Hold |
5
| – | – | ﹤0.01% | 5229 |
|
2024
Q4 | $29 | Sell |
5
-5
| -50% | -$29 | ﹤0.01% | 5284 |
|
2024
Q3 | $51 | Sell |
10
-43
| -81% | -$219 | ﹤0.01% | 5168 |
|
2024
Q2 | $96 | Buy |
53
+36
| +212% | +$65 | ﹤0.01% | 4973 |
|
2024
Q1 | $30 | Buy |
+17
| New | +$30 | ﹤0.01% | 5104 |
|
2023
Q4 | – | Sell |
-1,101
| Closed | -$1.61K | – | 5469 |
|
2023
Q3 | $1.61K | Buy |
+1,101
| New | +$1.61K | ﹤0.01% | 4586 |
|
2020
Q2 | – | Sell |
-400
| Closed | -$1K | – | 3654 |
|
2020
Q1 | $1K | Buy |
+400
| New | +$1K | ﹤0.01% | 3470 |
|
2019
Q4 | – | Sell |
-426,656
| Closed | -$1.28M | – | 3836 |
|
2019
Q3 | $1.28M | Sell |
426,656
-151,200
| -26% | -$455K | ﹤0.01% | 2378 |
|
2019
Q2 | $2.16M | Sell |
577,856
-267,700
| -32% | -$1M | ﹤0.01% | 2308 |
|
2019
Q1 | $3.4M | Sell |
845,556
-195,700
| -19% | -$787K | ﹤0.01% | 2181 |
|
2018
Q4 | $3.82M | Sell |
1,041,256
-977,556
| -48% | -$3.59M | ﹤0.01% | 2120 |
|
2018
Q3 | $17.3M | Sell |
2,018,812
-459,485
| -19% | -$3.94M | ﹤0.01% | 1737 |
|
2018
Q2 | $27.2M | Sell |
2,478,297
-73,823
| -3% | -$811K | ﹤0.01% | 1579 |
|
2018
Q1 | $29.4M | Buy |
2,552,120
+1,276,470
| +100% | +$14.7M | ﹤0.01% | 1539 |
|
2017
Q4 | $13.2M | Buy |
1,275,650
+421,139
| +49% | +$4.36M | ﹤0.01% | 1864 |
|
2017
Q3 | $13.6M | Sell |
854,511
-196,100
| -19% | -$3.13M | ﹤0.01% | 1835 |
|
2017
Q2 | $12.7M | Sell |
1,050,611
-1,072,495
| -51% | -$13M | ﹤0.01% | 1856 |
|
2017
Q1 | $44.1M | Sell |
2,123,106
-179,391
| -8% | -$3.73M | 0.01% | 1367 |
|
2016
Q4 | $32.9M | Buy |
2,302,497
+1,272,697
| +124% | +$18.2M | ﹤0.01% | 1485 |
|
2016
Q3 | $16.9M | Sell |
1,029,800
-1,281,497
| -55% | -$21.1M | ﹤0.01% | 1755 |
|
2016
Q2 | $33M | Buy |
2,311,297
+116,500
| +5% | +$1.66M | ﹤0.01% | 1452 |
|
2016
Q1 | $31.8M | Buy |
+2,194,797
| New | +$31.8M | ﹤0.01% | 1444 |
|